{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:00:27Z","timestamp":1779249627684,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.autrev.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T06:35:48Z","timestamp":1499668548000},"page":"903-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients"],"prefix":"10.1016","volume":"16","author":[{"given":"Arsene","family":"Mekinian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Dervin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanael","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Emmanuel","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Liozon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Grignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile Beyne","family":"Rauzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Grobost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Godmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Cardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Broner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Vinit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Ades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Carrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clementine","family":"Salvado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Versini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Baptiste","family":"Fraison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.07.003_bb0005","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study","author":"Mekinian","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2017.07.003_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000000011","article-title":"Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases","volume":"93","author":"Mekinian","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.003_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3324\/haematol.2011.044347","article-title":"Value of infliximab (Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group","volume":"97","author":"Baron","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.003_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/10428190400027829","article-title":"Infliximab chimeric antitumor necrosis factor-\u03b1 monoclonal antibody as potential treatment for myelodysplastic syndromes","volume":"46","author":"Stasi","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2017.07.003_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10428190109097683","article-title":"Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis\u2014Behcet's syndrome","volume":"42","author":"Kimura","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"2 Suppl 41","key":"10.1016\/j.autrev.2017.07.003_bb0030","first-page":"S31","article-title":"A case of arthritis and vasculitis associated with the refractory anemia with excess of blasts syndrome resistant to glucocorticoid treatment that responded favorably to TNF-alpha blockade","volume":"24","author":"Pipitone","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.003_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000355341","article-title":"Refractoriness of intestinal Behcet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies \u2014 our case experience and review of the literature","volume":"88","author":"Toyonaga","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.autrev.2017.07.003_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.leukres.2016.02.005","article-title":"Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Fraison","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.autrev.2017.07.003_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"10.1016\/j.autrev.2017.07.003_bb0050","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.leukres.2013.04.007","article-title":"Myelodysplastic syndromes and autoimmune diseases\u2014case series and review of literature","volume":"37","author":"Al Ustwani","year":"2013","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.autrev.2017.07.003_bb0055","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.leukres.2010.12.015","article-title":"Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells","volume":"35","author":"Al Ustwani","year":"2011","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.autrev.2017.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/acr.20504","article-title":"Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study","volume":"63","author":"de Hollanda","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.autrev.2017.07.003_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br J Haematol"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2017.07.003_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/10428199709055585","article-title":"Autoimmune phenomena in patients with myelodysplastic syndromes","volume":"24","author":"Enright","year":"1997","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.autrev.2017.07.003_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.leu.2402356","article-title":"Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study","volume":"16","author":"Deeg","year":"2002","journal-title":"Leukemia"},{"issue":"6 Pt 2","key":"10.1016\/j.autrev.2017.07.003_bb0080","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.lpm.2015.04.010","article-title":"Biologics in vasculitides: where do we stand, where do we go from now?","volume":"44","author":"Pazzola","year":"2015","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.003_bb0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.autrev.2017.02.008","article-title":"Intravenous immunoglobulins in systemic sclerosis: data from a French nationwide cohort of 46 patients and review of the literature","volume":"16","author":"Sanges","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2017.07.003_bb0090","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1002\/ajh.24333","article-title":"Autoimmune diseases and myelodysplastic syndromes","volume":"91","author":"Komrokji","year":"2016","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.autrev.2017.07.003_bb0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/tid.12130","article-title":"Epidemiology and risk factors for infections in myelodysplastic syndromes","volume":"15","author":"Sullivan","year":"2013","journal-title":"Transpl Infect Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T11:53:24Z","timestamp":1535630004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1568997217301714"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}